Ligand Binding Assay

Ligand Binding Assay refers to analytical methods that quantify the interaction between a ligand and its biological target, enabling measurement of binding affinity, kinetics, specificity, and receptor occupancy. These assays may involve labelled or label-free formats and are used to characterise molecular recognition events essential for drug discovery. Common approaches include radioligand binding assays, fluorescence polarisation, surface plasmon resonance, bio-layer interferometry, and immunoassays depending on target type and information requirements.

The pharmaceutical industry uses ligand binding assays extensively across lead identification, lead optimisation, and regulatory documentation. Competitive binding assays assess whether a candidate compound can displace a known ligand, supporting potency ranking and selectivity profiling. Saturation binding assays provide key parameters such as dissociation constants and receptor density. For biologics, ligand binding assays may measure antibody binding to antigens or biomarker levels in clinical samples. Assay development requires careful optimisation to minimise non-specific binding, matrix interference, and signal variability, with validation demonstrating accuracy, precision, sensitivity, and robustness. As therapeutic modalities expand into complex targets and multispecific formats, ligand binding assays remain essential tools translating molecular interactions into quantitative evidence.